The development of live attenuated cold-adapted influenza virus vaccine for humans.
about
Reverse Genetics Approaches for the Development of Influenza VaccinesA pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizationsCloning of the canine RNA polymerase I promoter and establishment of reverse genetics for influenza A and B in MDCK cells.Plasmid-only rescue of influenza A virus vaccine candidates.Vaccines for pandemic influenzaHost defense mechanism-based rational design of live vaccineSeasonal influenza vaccination and technologies.All-in-one bacmids: an efficient reverse genetics strategy for influenza A virus vaccines.The matrix gene segment destabilizes the acid and thermal stability of the hemagglutinin of pandemic live attenuated influenza virus vaccinesA live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets.Efficient generation of influenza virus with a mouse RNA polymerase I-driven all-in-one plasmidSafety, immunogenicity and infectivity of new live attenuated influenza vaccines.Safety, immunogencity, and efficacy of a cold-adapted A/Ann Arbor/6/60 (H2N2) vaccine in mice and ferretsAdvances in novel influenza vaccines: a patent review.Reversion of Cold-Adapted Live Attenuated Influenza Vaccine into a Pathogenic VirusNS-based live attenuated H1N1 pandemic vaccines protect mice and ferretsImmunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein.Engineering temperature sensitive live attenuated influenza vaccines from emerging viruses.Comparative study of influenza virus replication in MDCK cells and in primary cells derived from adenoids and airway epithelium.Immunization with a hemagglutinin-derived synthetic peptide formulated with a CpG-DNA-liposome complex induced protection against lethal influenza virus infection in mice.Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells.Development of a high-yield live attenuated H7N9 influenza virus vaccine that provides protection against homologous and heterologous H7 wild-type viruses in ferretsEfficacy of Live-Attenuated H9N2 Influenza Vaccine Candidates Containing NS1 Truncations against H9N2 Avian Influenza VirusesInfluenza A virus can undergo multiple cycles of replication without M2 ion channel activity.Attenuation of equine influenza viruses through truncations of the NS1 proteinHyperattenuated recombinant influenza A virus nonstructural-protein-encoding vectors induce human immunodeficiency virus type 1 Nef-specific systemic and mucosal immune responses in mice.Cellular scent of influenza virus infection.Mucosal immune network in the gut for the control of infectious diseases.Tobacco smoke exposure and altered nasal responses to live attenuated influenza virus.Generation of influenza A virus from cloned cDNAs--historical perspective and outlook for the new millenium.Selective incorporation of influenza virus RNA segments into virions.Generation of influenza A viruses with chimeric (type A/B) hemagglutinins.Live attenuated influenza virus (LAIV) induces different mucosal T cell function in nonsmokers and smokers.Alteration of the nasal responses to influenza virus by tobacco smokeInduction of protective CD4+ T cell-mediated immunity by a Leishmania peptide delivered in recombinant influenza viruses.Application of real time RT-PCR for the genetic homogeneity and stability tests of the seed candidates for live attenuated influenza vaccine production.Engineering influenza viral vectorsImplementation of new approaches for generating conventional reassortants for live attenuated influenza vaccine based on Russian master donor viruses.Traditional and new influenza vaccinesAn eight-segment swine influenza virus harboring H1 and H3 hemagglutinins is attenuated and protective against H1N1 and H3N2 subtypes in pigs.
P2860
Q28076140-571BFAB4-66D6-4C27-AC7C-9C6073766E14Q28749671-AFFD13D2-E383-43F1-A808-9758EDCB6583Q30229314-322EAC3A-CB82-4F98-83E5-7E3C0A3918EEQ30329368-D51842B5-D675-48D2-9DB0-748A088E839EQ30353073-6285B7EA-C61C-4BCA-BA04-9C5C4B0D4673Q30354189-EB895E78-FC77-48AB-8FF4-32C1D409815FQ30360897-51DE46E7-15BB-4528-A3E5-10F6F4D2311DQ30363730-063CCB05-863A-44C5-A547-6BD9C7BEAFB2Q30365696-C9A578AE-695C-4C36-88A9-C56789BC40AFQ30370303-9EF180B0-1123-4944-A472-522927D19F90Q30375917-0DB4032B-F88F-4BAD-959A-2E43A03EE9C9Q30378132-497346BD-7160-41DB-814F-BACC7428F799Q30383905-E47F97DE-57D4-4919-888B-A402B09739FBQ30388514-E4796B08-F5BB-45B5-A014-D40DDD4B8142Q30390811-D69F8A3B-DAAB-45A3-971F-EF436C71CCE6Q30394706-A9174D4C-7444-4442-9C62-9175F8B3E6DDQ30398731-16711B10-9498-4CED-8F0D-CB61074F1DA8Q30414665-5D961812-D800-42A7-ABD3-D0833A88761FQ30420603-719ECEFD-011A-43B3-ABBE-38A443939D8CQ30423481-0FE5617B-3554-4A49-BC93-530B296358D1Q30474419-79F88AF0-284B-4281-B433-4D671FECB3AEQ33743763-EB597474-302B-43C3-A564-CEA354AAAC29Q33794563-F3B781D4-D248-4F88-B359-364FEF4338B2Q33842032-C42BBC29-5E5E-4A0D-A9B2-09C8E596A363Q33843410-4F6BD46E-C65C-4053-A153-628EFB7AE2D8Q33844931-EFDA41E4-EBE9-411E-BF4B-4D85977B8F0CQ33923347-210F0796-C2C1-423D-993C-61DB91B8F010Q34191806-1927C403-0E56-4809-9F32-6212E1F54198Q34478558-BF5D5AAB-0381-4608-B05B-12E2CD65E20AQ34490251-D0276F41-8F6D-41DE-A8D0-82C1060F36C6Q34762920-DEB3E797-5177-4FBB-AE4A-68201066083EQ35104829-9EE9CDCD-2DE7-43D9-BAFF-F95F5EDAEEE6Q35784077-9F26FC20-2AE1-440E-9E02-BA55344A88CBQ35835252-CE42BD21-8E9B-4081-803C-207C4989EEAEQ35845737-7D6E3BDB-E4FA-484D-914E-4ADBAE469141Q36165344-BFCA43B0-6F47-4456-A57E-13C97E74BF75Q36591871-FBD47C83-2BA8-4D29-9F5F-1428EFEB402DQ36637886-EE69F24B-2186-4510-BE18-41CADB94E913Q37035833-89C7B375-338A-414F-B389-DA6667F3C36BQ37123091-D1EB6FE1-1A21-47DB-BEA1-8CFD86DEB498
P2860
The development of live attenuated cold-adapted influenza virus vaccine for humans.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The development of live attenuated cold-adapted influenza virus vaccine for humans.
@ast
The development of live attenuated cold-adapted influenza virus vaccine for humans.
@en
type
label
The development of live attenuated cold-adapted influenza virus vaccine for humans.
@ast
The development of live attenuated cold-adapted influenza virus vaccine for humans.
@en
prefLabel
The development of live attenuated cold-adapted influenza virus vaccine for humans.
@ast
The development of live attenuated cold-adapted influenza virus vaccine for humans.
@en
P2860
P1476
The development of live attenuated cold-adapted influenza virus vaccine for humans.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1099-1654(199910/12)9:4<237::AID-RMV252>3.0.CO;2-G
P577
1999-10-01T00:00:00Z